- Product Details
Keywords
- Tesamorelin
- Tesamorelin
- Tesamorelin
Quick Details
- ProName: Pharmaceutical peptides 2mg 99% Tesamo...
- CasNo: 218949-48-5
- Molecular Formula: C18H13ClF4N2O3
- Appearance: white powder
- Application: used by athletes to assist in training...
- DeliveryTime: immediately
- PackAge: aluminum foil bag
- Port: HK, Shanghai, Shenzhen
- ProductionCapacity: 100 Kilogram/Month
- Purity: 99%
- Storage: cool and dry place
- Transportation: EMS,DHL,HK post,EUB,ETK,NL post,German...
- LimitNum: 1 Gram
Superiority
Details
Tesamorelin (also known as Egrifta) is a synthetic form which is used in the treatment of HIV-associated lipodystrophy.
Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals. Lipodystrophy is a condition that causes changes in placement of body fat, including wasting and fat accumulation, and changes in metabolism.
Storage: Tesamorelin peptides although stable at room temperature for 3 months, should be stored desiccated below -18° C.
Upon reconstitution of the peptide it should be stored at 4° C between 2-21 days and for future use below -18° C.
Applications:
Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals as well as similarly reducing abdominal fat in NON-HIV-Infected individuals.
Studied as a way to reduce excess deep belly fat, the synthetic human growth hormone releasing factor called tesamorelin (Egrifta) was approved by the FDA in November 2010 and has been available since January 2011. Results from a 52-week study of 816 people showed 18% less deep belly fat in those on tesamorelin than those taking placebo
Do NOT use tesamorelin if:
you are allergic to any ingredient in tesamorelin or to mannitol
you are pregnant
you have cancer, an underactive pituitary gland, or a pituitary gland tumor
you have had your pituitary gland removed, pituitary gland surgery, radiation treatment of the head, or a head injury
Contact your doctor or health care provider right away if any of these apply to you.
Packing and shipping